Skip to main content
Erschienen in: Strahlentherapie und Onkologie 5/2013

01.05.2013 | Original article

Effect of a combined surgery, re-irradiation and hyperthermia therapy on local control rate in radio-induced angiosarcoma of the chest wall

verfasst von: M. Linthorst, MD., A.N. van Geel, M.D., Ph.D, E.A. Baartman, M.D., S.B. Oei, M.D., W. Ghidey, Ph.D., G.C. van Rhoon, Ph.D., J. van der Zee, M.D., Ph.D.

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Radiation-induced angiosarcoma (RAS) of the chest wall/breast has a poor prognosis due to the high percentage of local failures. The efficacy and side effects of re-irradiation plus hyperthermia (reRT + HT) treatment alone or in combination with surgery were assessed in RAS patients.

Patients and methods

RAS was diagnosed in 23 breast cancer patients and 1 patient with melanoma. These patients had previously undergone breast conserving therapy (BCT, n = 18), mastectomy with irradiation (n=5) or axillary lymph node dissection with irradiation (n = 1). Treatment consisted of surgery followed by reRT + HT (n = 8), reRT + HT followed by surgery (n = 3) or reRT + HT alone (n = 13). Patients received a mean radiation dose of 35 Gy (32–54 Gy) and 3–6 hyperthermia treatments (mean 4). Hyperthermia was given once or twice a week following radiotherapy (RT).

Results

The median latency interval between previous radiation and diagnosis of RAS was 106 months (range 45–212 months). Following reRT + HT, the complete response (CR) rate was 56 %. In the subgroup of patients receiving surgery, the 3-month, 1- and 3-year actuarial local control (LC) rates were 91, 46 and 46 %, respectively. In the subgroup of patients without surgery, the rates were 54, 32 and 22 %, respectively. Late grade 4 RT toxicity was seen in 2 patients.

Conclusion

The present study shows that reRT + HT treatment—either alone or combined with surgery—improves LC rates in patients with RAS.
Literatur
1.
Zurück zum Zitat Abraham JA, Hornicek FJ, Kaufman Harmon DC et al (2007) Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol 14:1953–1967PubMedCrossRef Abraham JA, Hornicek FJ, Kaufman Harmon DC et al (2007) Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol 14:1953–1967PubMedCrossRef
2.
Zurück zum Zitat Bakker JF, Paulides MM, Westra AH et al (2010) Design and test of a 434 MHz multi-channel amplifier system for targeted hyperthermia applicators. Int J Hyperthermia 26:158–170PubMedCrossRef Bakker JF, Paulides MM, Westra AH et al (2010) Design and test of a 434 MHz multi-channel amplifier system for targeted hyperthermia applicators. Int J Hyperthermia 26:158–170PubMedCrossRef
3.
Zurück zum Zitat Billings SD, McKenney JK, Folpe AL et al (2004) Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. Am J Surg Pathol 28:781–788PubMedCrossRef Billings SD, McKenney JK, Folpe AL et al (2004) Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. Am J Surg Pathol 28:781–788PubMedCrossRef
4.
Zurück zum Zitat De Bruijne M, Wielheesen DH, Zee J van der et al (2007) Benefits of superficial hyperthermia treatment planning: five case studies. Int J Hyperthermia 23:417–429CrossRef De Bruijne M, Wielheesen DH, Zee J van der et al (2007) Benefits of superficial hyperthermia treatment planning: five case studies. Int J Hyperthermia 23:417–429CrossRef
5.
Zurück zum Zitat De Bruijne M, Van der Zee J, Ameziane A, Rhoon GC van (2011) Quality control of superficial hyperthermia by treatment evaluation. Int J Hyperthermia 27:199–213CrossRef De Bruijne M, Van der Zee J, Ameziane A, Rhoon GC van (2011) Quality control of superficial hyperthermia by treatment evaluation. Int J Hyperthermia 27:199–213CrossRef
6.
Zurück zum Zitat De Bruijne M, Holt B van der, Rhoon GC van, Zee J van der (2010) Evaluation of CEM43 degrees CT90 thermal dose in superficial hyperthermia: a retrospective analysis. Strahlenther Onkol 186:436–443CrossRef De Bruijne M, Holt B van der, Rhoon GC van, Zee J van der (2010) Evaluation of CEM43 degrees CT90 thermal dose in superficial hyperthermia: a retrospective analysis. Strahlenther Onkol 186:436–443CrossRef
7.
Zurück zum Zitat De Jong MA, Oldenborg S, Oei SB et al (2011) Reirradiation and hyperthermia for radiation-associated sarcoma. Cancer 118:180–187 De Jong MA, Oldenborg S, Oei SB et al (2011) Reirradiation and hyperthermia for radiation-associated sarcoma. Cancer 118:180–187
8.
Zurück zum Zitat Fodor J, Orosz Z, Szabó E et al (2006) Angiosarcoma after conservation treatment for breast carcinoma: our experience and a review of the literature. J Am Acad Dermatol 54:499–504PubMedCrossRef Fodor J, Orosz Z, Szabó E et al (2006) Angiosarcoma after conservation treatment for breast carcinoma: our experience and a review of the literature. J Am Acad Dermatol 54:499–504PubMedCrossRef
9.
Zurück zum Zitat Fraga-Guedes C, Gobbi H, Mastropasqua MG et al (2012) Primary and secondary angiosarcomas of the breast: a single institution experience. Breast Cancer Res Treat 132:1081–1088PubMedCrossRef Fraga-Guedes C, Gobbi H, Mastropasqua MG et al (2012) Primary and secondary angiosarcomas of the breast: a single institution experience. Breast Cancer Res Treat 132:1081–1088PubMedCrossRef
10.
Zurück zum Zitat Gelvich EA, Mazokhin VN (2002) Contact flexible microstrip applicators (CFMA) in a range from microwaves up to short waves. IEEE Trans Biomed Eng 49:1015–1023PubMedCrossRef Gelvich EA, Mazokhin VN (2002) Contact flexible microstrip applicators (CFMA) in a range from microwaves up to short waves. IEEE Trans Biomed Eng 49:1015–1023PubMedCrossRef
11.
Zurück zum Zitat Hand JW, Machin D, Vernon CC, Whaley JB (1997) Analysis of thermal parameters obtained during phase III trials of hyperthermia as an adjunct to radiotherapy in the treatment of breast carcinoma. Int J Hyperthermia 13:343–364PubMedCrossRef Hand JW, Machin D, Vernon CC, Whaley JB (1997) Analysis of thermal parameters obtained during phase III trials of hyperthermia as an adjunct to radiotherapy in the treatment of breast carcinoma. Int J Hyperthermia 13:343–364PubMedCrossRef
12.
Zurück zum Zitat Herskind C, Wenz F (2010) Radiobiological comparison of hypofractionated accelerated partial-breast irradiation (APBI) and single-dose intraoperative radiotherapy (IORT) with 50-kV X-rays. Strahlenther Onkol 186:444–451PubMedCrossRef Herskind C, Wenz F (2010) Radiobiological comparison of hypofractionated accelerated partial-breast irradiation (APBI) and single-dose intraoperative radiotherapy (IORT) with 50-kV X-rays. Strahlenther Onkol 186:444–451PubMedCrossRef
13.
Zurück zum Zitat Jallali N, James S, Searle A et al (2012) Surgical management of radiation-induced angiosarcoma after breast conservation therapy. Am J Surg 203:156–161PubMedCrossRef Jallali N, James S, Searle A et al (2012) Surgical management of radiation-induced angiosarcoma after breast conservation therapy. Am J Surg 203:156–161PubMedCrossRef
14.
Zurück zum Zitat Jones EL, Oleson JR, Prosnitz LR et al (2005) Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23:3079–3085PubMedCrossRef Jones EL, Oleson JR, Prosnitz LR et al (2005) Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23:3079–3085PubMedCrossRef
15.
Zurück zum Zitat Kok HP, Greef M de, Correia D et al (2009) FDTD simulations to assess the performance of CFMA-434 applicators for superficial hyperthermia. Int J Hyperthermia 25:462–476PubMedCrossRef Kok HP, Greef M de, Correia D et al (2009) FDTD simulations to assess the performance of CFMA-434 applicators for superficial hyperthermia. Int J Hyperthermia 25:462–476PubMedCrossRef
16.
Zurück zum Zitat Lindford A, Bohling T, Vaalavirta L et al (2011) Surgical management of radiation-associated cutaneous breast angiosarcoma. J Plast Reconstr Aesthet Surg 64:1036–1042PubMedCrossRef Lindford A, Bohling T, Vaalavirta L et al (2011) Surgical management of radiation-associated cutaneous breast angiosarcoma. J Plast Reconstr Aesthet Surg 64:1036–1042PubMedCrossRef
17.
Zurück zum Zitat Linthorst M, Drizdal T, Joosten H et al (2011) Procedure for creating a three-dimensional (3D) model for superficial hyperthermia treatment planning. Strahlenther Onkol 187:835–841PubMedCrossRef Linthorst M, Drizdal T, Joosten H et al (2011) Procedure for creating a three-dimensional (3D) model for superficial hyperthermia treatment planning. Strahlenther Onkol 187:835–841PubMedCrossRef
18.
Zurück zum Zitat Marchal C, Weber B, LaFontan B de et al (1999) Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French Comprehensive Cancer Centers. Int J Radiat Oncol Biol Phys 44:113–119PubMedCrossRef Marchal C, Weber B, LaFontan B de et al (1999) Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French Comprehensive Cancer Centers. Int J Radiat Oncol Biol Phys 44:113–119PubMedCrossRef
19.
Zurück zum Zitat Mery CM, George S, Bertagnolli MM, Raut CP (2009) Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival. Cancer 115:4055–4063PubMedCrossRef Mery CM, George S, Bertagnolli MM, Raut CP (2009) Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival. Cancer 115:4055–4063PubMedCrossRef
20.
Zurück zum Zitat Monroe AT, Feigenberg SJ, Mendenhall NP (2003) Angiosarcoma after breast-conserving therapy. Cancer 97:1832–1840PubMedCrossRef Monroe AT, Feigenberg SJ, Mendenhall NP (2003) Angiosarcoma after breast-conserving therapy. Cancer 97:1832–1840PubMedCrossRef
21.
Zurück zum Zitat Müller AC, Eckert F, Heinrich V et al (2011) Re-surgery and chest wall re-irradiation for recurrent breast cancer—a second curative approach. BMC Cancer 11:1–8CrossRef Müller AC, Eckert F, Heinrich V et al (2011) Re-surgery and chest wall re-irradiation for recurrent breast cancer—a second curative approach. BMC Cancer 11:1–8CrossRef
22.
Zurück zum Zitat Nestle-Krämling C, Bolke E, Budach W et al (2011) Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review. Strahlenther Onkol 187:656–664PubMedCrossRef Nestle-Krämling C, Bolke E, Budach W et al (2011) Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review. Strahlenther Onkol 187:656–664PubMedCrossRef
23.
Zurück zum Zitat Palta M, Morris CG, Grobmyer SR et al (2010) Angiosarcoma after breast-conserving therapy: long-term outcomes with hyperfractionated radiotherapy. Cancer 116:1872–1878PubMedCrossRef Palta M, Morris CG, Grobmyer SR et al (2010) Angiosarcoma after breast-conserving therapy: long-term outcomes with hyperfractionated radiotherapy. Cancer 116:1872–1878PubMedCrossRef
24.
Zurück zum Zitat Polgar C, Strnad V, Kovacs G (2010) Partial-breast irradiation or whole-breast radiotherapy for early breast cancer: a meta-analysis of randomized trials. Strahlenther Onkol 186:113–114PubMedCrossRef Polgar C, Strnad V, Kovacs G (2010) Partial-breast irradiation or whole-breast radiotherapy for early breast cancer: a meta-analysis of randomized trials. Strahlenther Onkol 186:113–114PubMedCrossRef
25.
Zurück zum Zitat Rao J, Dekoven JG, Beatty JD, Jones G (2003) Cutaneous angiosarcoma as a delayed complication of radiation therapy for carcinoma of the breast. J Am Acad Dermatol 49:532–538PubMedCrossRef Rao J, Dekoven JG, Beatty JD, Jones G (2003) Cutaneous angiosarcoma as a delayed complication of radiation therapy for carcinoma of the breast. J Am Acad Dermatol 49:532–538PubMedCrossRef
26.
Zurück zum Zitat Sauer R, Creeze H, Hulshof M et al (2012) Concerning the final report “Hyperthermia: a systematic review” of the Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, March 2010. Strahlenther Onkol 188:209–213PubMedCrossRef Sauer R, Creeze H, Hulshof M et al (2012) Concerning the final report “Hyperthermia: a systematic review” of the Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, March 2010. Strahlenther Onkol 188:209–213PubMedCrossRef
27.
Zurück zum Zitat Sautter-Bihl ML, Sedlmayer F, Budach W et al (2012) When are breast cancer patients old enough for the quitclaim of local control? Strahlenther Onkol 188:1069–1073PubMedCrossRef Sautter-Bihl ML, Sedlmayer F, Budach W et al (2012) When are breast cancer patients old enough for the quitclaim of local control? Strahlenther Onkol 188:1069–1073PubMedCrossRef
28.
Zurück zum Zitat Scott MT, Portnow LH, Morris CG et al (2012) Radiation therapy for angiosarcoma: the 35-year University of Florida Experience. Am J Clin Oncol (Epub ahead of print) Scott MT, Portnow LH, Morris CG et al (2012) Radiation therapy for angiosarcoma: the 35-year University of Florida Experience. Am J Clin Oncol (Epub ahead of print)
29.
Zurück zum Zitat Seinen JM, Styring E, Verstappen V et al (2012) Radiation-associated angiosarcoma after breast cancer: high recurrence rate and poor survival despite surgical treatment with R0 resection. Ann Surg Oncol (Epub ahead of print) Seinen JM, Styring E, Verstappen V et al (2012) Radiation-associated angiosarcoma after breast cancer: high recurrence rate and poor survival despite surgical treatment with R0 resection. Ann Surg Oncol (Epub ahead of print)
30.
Zurück zum Zitat Stieler F, Wenz F, Scherrer D et al (2012) Clinical evaluation of a commercial surface-imaging system for patient positioning in radiotherapy. Strahlenther Onkol 188:1080–1084PubMedCrossRef Stieler F, Wenz F, Scherrer D et al (2012) Clinical evaluation of a commercial surface-imaging system for patient positioning in radiotherapy. Strahlenther Onkol 188:1080–1084PubMedCrossRef
31.
Zurück zum Zitat Styring E, Fernebro J, Jönsson PE et al (2010) Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall. Breast Cancer Res Treat 122:883–887PubMedCrossRef Styring E, Fernebro J, Jönsson PE et al (2010) Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall. Breast Cancer Res Treat 122:883–887PubMedCrossRef
32.
Zurück zum Zitat Matuschek C, Bölke E, Roth SL et al (2012) Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission: results of a multivariate analysis. Strahlenther Onkol 188:777–781PubMedCrossRef Matuschek C, Bölke E, Roth SL et al (2012) Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission: results of a multivariate analysis. Strahlenther Onkol 188:777–781PubMedCrossRef
33.
Zurück zum Zitat Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176–181PubMedCrossRef Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176–181PubMedCrossRef
34.
Zurück zum Zitat Van der Gaag ML, De Bruijne M, Samaras T et al (2006) Development of a guideline for the water bolus temperature in superficial hyperthermia. Int J Hyperthermia 22:637–656CrossRef Van der Gaag ML, De Bruijne M, Samaras T et al (2006) Development of a guideline for the water bolus temperature in superficial hyperthermia. Int J Hyperthermia 22:637–656CrossRef
35.
Zurück zum Zitat Van der Zee J, De Bruijne M, Mens JW et al (2010) Reirradiation combined with hyperthermia in breast cancer recurrences: overview of experience in Erasmus MC. Int J Hyperthermia 26:638–648CrossRef Van der Zee J, De Bruijne M, Mens JW et al (2010) Reirradiation combined with hyperthermia in breast cancer recurrences: overview of experience in Erasmus MC. Int J Hyperthermia 26:638–648CrossRef
36.
Zurück zum Zitat Vernon CC, Hand JW, Field SB et al (1996) Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer—results from five randomized controlled trials. Int J Radiation Oncology Biol Phys 35:731–744CrossRef Vernon CC, Hand JW, Field SB et al (1996) Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer—results from five randomized controlled trials. Int J Radiation Oncology Biol Phys 35:731–744CrossRef
37.
Zurück zum Zitat Vorburger SA, Xing Y, Hunt KK et al (2005) Angiosarcoma of the breast. Cancer 104:2682–2688PubMedCrossRef Vorburger SA, Xing Y, Hunt KK et al (2005) Angiosarcoma of the breast. Cancer 104:2682–2688PubMedCrossRef
38.
Zurück zum Zitat Koeck J, Abo-Madyan Y, Eich HT et al (2012) Clinical relevance of different dose calculation strategies for mediastinal IMRT in Hodgkin’s disease. 8trahlenther Onkol 188:653–659CrossRef Koeck J, Abo-Madyan Y, Eich HT et al (2012) Clinical relevance of different dose calculation strategies for mediastinal IMRT in Hodgkin’s disease. 8trahlenther Onkol 188:653–659CrossRef
39.
Zurück zum Zitat West JG, Qureshi A, West JE et al (2005) Risk of angiosarcoma following breast conservation: a clinical alert. Breast J 11:115–123PubMedCrossRef West JG, Qureshi A, West JE et al (2005) Risk of angiosarcoma following breast conservation: a clinical alert. Breast J 11:115–123PubMedCrossRef
40.
Zurück zum Zitat Wijnmaalen A, Ooijen B van, Geel BN van et al (1993) Angiosarcoma of the breast following lumpectomy, axillary lymph node dissection, and radiotherapy for primary breast cancer: three case reports and a review of the literature. Int J Radiat Oncol Biol Phys 26:135–139PubMedCrossRef Wijnmaalen A, Ooijen B van, Geel BN van et al (1993) Angiosarcoma of the breast following lumpectomy, axillary lymph node dissection, and radiotherapy for primary breast cancer: three case reports and a review of the literature. Int J Radiat Oncol Biol Phys 26:135–139PubMedCrossRef
Metadaten
Titel
Effect of a combined surgery, re-irradiation and hyperthermia therapy on local control rate in radio-induced angiosarcoma of the chest wall
verfasst von
M. Linthorst, MD.
A.N. van Geel, M.D., Ph.D
E.A. Baartman, M.D.
S.B. Oei, M.D.
W. Ghidey, Ph.D.
G.C. van Rhoon, Ph.D.
J. van der Zee, M.D., Ph.D.
Publikationsdatum
01.05.2013
Verlag
Springer-Verlag
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 5/2013
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-013-0316-3

Weitere Artikel der Ausgabe 5/2013

Strahlentherapie und Onkologie 5/2013 Zur Ausgabe

Mitteilungen der Fachgesellschaften

Mitteilungen der Fachgesellschaften

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.